Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 disease: Malacards - Research Articles, Drugs, Genes, Clinical Trials

PEOA4 MCID: PRG040 MIFTS: 53	Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 (PEOA4) Categories: Bone diseases, Ear diseases, Eye diseases, Fetal diseases, Genetic diseases, Metabolic diseases, Muscle diseases, Neuronal diseases, Rare diseases, Respiratory diseases
Genes Variations Tissues Related diseases Publications Pathways Symptoms & Phenotypes Expand all tables

Sources

Aliases & Classifications for Progressive External Ophthalmoplegia with Mitochondrial Dna...

MalaCards integrated aliases for Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

Name: Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 ⁵⁷ ¹³

Autosomal Dominant Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions 4 ¹² ²⁹ ⁶ ¹⁵

Peoa4 ⁵⁷ ¹² ⁷³

Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant, 4 ⁷³ ⁷¹

Chronic Progressive External Ophthalmoplegia ⁷³ ⁷¹

Ophthalmoplegia, External, Progressive, with Mitochondrial Dna Deletions, Autosomal Dominant, Type 4 ³⁹

Progressive External Ophthalmoplegia, Autosomal Dominant 4 ⁵⁷

Autosomal Dominant Progressive External Ophthalmoplegia 4 ¹²

Progressive External Ophthalmoplegia Autosomal Dominant 4 ⁷³

Ocular Myopathy of Von Graefe-Fuchs ⁷³

Mitochondrial Ocular Myopathy ⁷³

Kearns-Sayre Syndrome ⁷¹

Graefe Disease ⁷³

Cpeo ⁷³

Characteristics:

OMIM®:

⁵⁷ (Updated 05-Mar-2021)

Inheritance:
autosomal dominant

Miscellaneous:
variable severity
progressive disorder
variable age at onset (range infancy to adult)

HPO:

³¹

progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 4:
Inheritance autosomal dominant inheritance
Onset and clinical course variable expressivity progressive adult onset

Classifications:

MalaCards categories:
Global: Genetic diseases Rare diseases Metabolic diseases Fetal diseases
Anatomical: Muscle diseases Neuronal diseases Eye diseases Ear diseases Respiratory diseases Bone diseases

See all MalaCards categories (disease lists)

External Ids:

Disease Ontology ¹² DOID:0111525

OMIM® ⁵⁷ 610131

OMIM Phenotypic Series ⁵⁷ PS157640

MeSH ⁴⁴ D017246

MedGen ⁴¹ C1864668

UMLS ⁷¹ C0022541 C0162674 C1864668

Sources

Summaries for Progressive External Ophthalmoplegia with Mitochondrial Dna...

UniProtKB/Swiss-Prot : ⁷³ Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 4: A disorder characterized by progressive weakness of ocular muscles and levator muscle of the upper eyelid. In a minority of cases, it is associated with skeletal myopathy, which predominantly involves axial or proximal muscles and which causes abnormal fatigability and even permanent muscle weakness. Ragged-red fibers and atrophy are found on muscle biopsy. A large proportion of chronic ophthalmoplegias are associated with other symptoms, leading to a multisystemic pattern of this disease. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism.

MalaCards based summary : Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4, also known as autosomal dominant progressive external ophthalmoplegia with mitochondrial dna deletions 4, is related to ptosis and chronic progressive external ophthalmoplegia, and has symptoms including seizures, muscle weakness and ophthalmoplegia. An important gene associated with Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 is POLG2 (DNA Polymerase Gamma 2, Accessory Subunit), and among its related pathways/superpathways are Mitochondrial Gene Expression and Propanoate metabolism. Affiliated tissues include skeletal muscle, liver and eye, and related phenotypes are failure to thrive and constipation

Disease Ontology : ¹² A chronic progressive external ophthalmoplegia that has material basis in heterozygous mutation in POLG2 on chromosome 17q23.3.

OMIM® : ⁵⁷ Progressive external ophthalmoplegia-4 is an autosomal dominant form of mitochondrial disease that variably affects skeletal muscle, the nervous system, the liver, and the gastrointestinal tract. Age at onset ranges from infancy to adulthood. The phenotype ranges from relatively mild, with adult-onset skeletal muscle weakness and weakness of the external eye muscles, to severe, with a multisystem disorder characterized by delayed psychomotor development, lactic acidosis, constipation, and liver involvement (summary by Young et al., 2011). For a general phenotypic description and a discussion of genetic heterogeneity of autosomal dominant progressive external ophthalmoplegia, see PEOA1 (157640). (610131) (Updated 05-Mar-2021)

Sources

Related Diseases for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Diseases in the Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 1 family:

Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Recessive 1	Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 2
Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 3	Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4
Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 5	Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 6
Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Recessive 2	Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Recessive 3
Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Recessive 4	Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Recessive 5

Diseases related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 159)

#	Related Disease	Score	Top Affiliating Genes
1	ptosis	31.0	TYMP TWNK RRM2B POLG
2	chronic progressive external ophthalmoplegia	30.9	TYMP TWNK SUCLG1 SUCLA2 SSBP1 SLC25A4
3	myopathy	30.2	TYMP TWNK SLC25A4 RRM2B POLG2 POLG
4	progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 1	30.2	TYMP TWNK SUCLG1 SUCLA2 SSBP1 SLC25A4
5	lactic acidosis	30.1	SUCLG1 SLC25A4 RRM2B POLG2 POLG
6	kearns-sayre syndrome	30.1	TYMP TWNK SUCLG1 SUCLA2 SSBP1 SLC25A4
7	mitochondrial neurogastrointestinal encephalomyopathy	29.9	TYMP RRM2B POLG
8	optic nerve disease	29.9	TWNK POLG MT-ND2 IMMT
9	mitochondrial disorders	29.8	TYMP TWNK SLC25A4 RRM2B POLG2 POLG
10	autosomal dominant progressive external ophthalmoplegia	29.6	TWNK SLC25A4 RRM2B POLG2 POLG
11	mitochondrial encephalomyopathy	29.5	TYMP TWNK SUCLG1 SUCLA2 POLG MT-ND2
12	mitochondrial metabolism disease	29.4	TWNK SUCLG1 SUCLA2 SLC25A4 RRM2B POLG2
13	mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes	29.4	TYMP TWNK POLG MT-ND2 DGUOK
14	neuropathy	29.4	TYMP TWNK SLC25A4 POLG MT-ND2 MPV17
15	mitochondrial myopathy	28.5	TYMP TWNK SUCLG1 SUCLA2 SSBP1 SLC25A4
16	3-methylglutaconic aciduria, type iii	28.4	TYMP TWNK SUCLG1 SUCLA2 SLC25A4 POLG2
17	sensory ataxic neuropathy, dysarthria, and ophthalmoparesis	28.2	TYMP TWNK SUCLG1 SUCLA2 SSBP1 SLC25A4
18	leigh syndrome	28.1	TWNK SUCLG1 SUCLA2 RRM2B POLG2 POLG
19	leber hereditary optic neuropathy, modifier of	27.7	TYMP TWNK SLC25A4 RRM2B POLG2 POLG
20	progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 2	11.8
21	progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 1	11.7
22	progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 3	11.7
23	progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 2	11.7
24	ocular muscular dystrophy	11.4
25	mitochondrial dna-related progressive external ophthalmoplegia	11.4
26	strabismus	11.3
27	progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 5	11.2
28	progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal dominant 6	11.2
29	progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 3	11.2
30	progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 4	11.2
31	progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 5	11.2
32	mechanical strabismus	10.5
33	dysphagia	10.5
34	branchiootic syndrome 1	10.4
35	alternating exotropia	10.4
36	exotropia	10.4
37	myasthenia gravis	10.4
38	retinitis pigmentosa	10.4
39	ataxia, combined cerebellar and peripheral, with hearing loss and diabetes mellitus	10.4
40	neuroretinitis	10.4
41	retinitis	10.4
42	hereditary optic neuropathy	10.4
43	ataxia and polyneuropathy, adult-onset	10.3
44	lagophthalmos	10.3
45	peripheral nervous system disease	10.3
46	keratitis, hereditary	10.2
47	optic atrophy 1	10.2
48	atrioventricular block	10.2
49	sensorineural hearing loss	10.2
50	monocular esotropia	10.2

Graphical network of the top 20 diseases related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

Diseases related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4

Sources

Symptoms & Phenotypes for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Human phenotypes related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

³¹ (show all 24)

#	Description	HPO Frequency	HPO Source Accession
1	failure to thrive ³¹	occasional (7.5%)	HP:0001508
2	constipation ³¹	occasional (7.5%)	HP:0002019
3	global developmental delay ³¹	occasional (7.5%)	HP:0001263
4	gastroesophageal reflux ³¹	occasional (7.5%)	HP:0002020
5	elevated hepatic transaminase ³¹	occasional (7.5%)	HP:0002910
6	abnormality of the liver ³¹	occasional (7.5%)	HP:0001392
7	cerebellar atrophy ³¹	occasional (7.5%)	HP:0001272
8	generalized hypotonia ³¹	occasional (7.5%)	HP:0001290
9	gastroparesis ³¹	occasional (7.5%)	HP:0002578
10	cerebral visual impairment ³¹	occasional (7.5%)	HP:0100704
11	seizure ³¹	occasional (7.5%)	HP:0001250
12	ptosis ³¹		HP:0000508
13	facial palsy ³¹		HP:0010628
14	elevated serum creatine kinase ³¹		HP:0003236
15	progressive external ophthalmoplegia ³¹		HP:0000590
16	myalgia ³¹		HP:0003326
17	arrhythmia ³¹		HP:0011675
18	increased serum lactate ³¹		HP:0002151
19	limb muscle weakness ³¹		HP:0003690
20	progressive muscle weakness ³¹		HP:0003323
21	exercise intolerance ³¹		HP:0003546
22	cytochrome c oxidase-negative muscle fibers ³¹		HP:0003688
23	impaired glucose tolerance ³¹		HP:0040270
24	multiple mitochondrial dna deletions ³¹		HP:0003689

Symptoms via clinical synopsis from OMIM®:

⁵⁷ (Updated 05-Mar-2021)

Head And Neck Eyes:
ptosis
external ophthalmoplegia, progressive (peo)
cortical blindness (1 patient)

Muscle Soft Tissue:
limb muscle weakness
exercise intolerance
muscle pain
facial muscle weakness
muscle weakness, progressive
more

Cardiovascular Heart:
cardiac conduction defects

Growth Other:
failure to thrive (in some patients)

Abdomen Liver:
liver disease (in some patients)

Laboratory Abnormalities:
increased serum lactate
increased serum creatine kinase
abnormal liver enzymes (in some patients)

Endocrine Features:
impaired glucose tolerance

Neurologic Central Nervous System:
seizures (in some patients)
developmental delay (in some patients)
hypotonia (in some patients)
cerebellar atrophy (1 patient)

Abdomen Gastrointestinal:
gastroesophageal reflux (in some patients)
constipation (in some patients)
delayed gastric emptying (in some patients)

Clinical features from OMIM®:

610131 (Updated 05-Mar-2021)

UMLS symptoms related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

seizures, muscle weakness, ophthalmoplegia, myalgia, cerebellar ataxia, facial paresis

MGI Mouse Phenotypes related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

⁴⁶

#	Description	MGI Source Accession	Score	Top Affiliating Genes
1	cellular	MP:0005384	9.7	DGUOK MPV17 MT-ND2 POLG POLG2 RRM2B
2	mortality/aging	MP:0010768	9.36	DGUOK INTS2 MPV17 POLG POLG2 RRM2B

Sources

Drugs & Therapeutics for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Interventional clinical trials:

#	Name	Status	NCT ID
1	Magnetic Resonance Imaging Study of Patients With Chronic Progressive External Ophthalmoplegia	Completed	NCT02161848
2	Effect Of The System In The Enriched Fat Metabolism Of The Child Reached Mitochondrial Cytopathy	Completed	NCT02385565
3	Nutritional Assessment in Patients Affected by Mitochondrial Cytopathy	Completed	NCT02375438
4	Foundation Fighting Blindness Registry, My Retina Tracker	Recruiting	NCT02435940

Search NIH Clinical Center for Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4

Sources

Genetic Tests for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Genetic tests related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

#	Genetic test	Affiliating Genes
1	Autosomal Dominant Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions 4 ²⁹	POLG2

Sources

Anatomical Context for Progressive External Ophthalmoplegia with Mitochondrial Dna...

MalaCards organs/tissues related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

⁴⁰

Skeletal Muscle, Liver, Eye, Retina, Brain, Heart, Endothelial

Sources

Publications for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Articles related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

(show top 50) (show all 525)

#	Title	Authors	PMID	Year
1	Biochemical analysis of human POLG2 variants associated with mitochondrial disease. ⁵⁷ ⁶	Young MJ...Copeland WC	21555342	2011
2	Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. ⁶ ⁵⁷	Longley MJ...Chinnery PF	16685652	2006
3	Severe Chronic Progressive External Ophthalmoplegia-Associated Ptosis Successfully Treated With Scleral Lenses: Response. ⁶¹	Cherny C...Dagi Glass LR	32868563	2021
4	Complete genome sequence and bioinformatics analysis of nine Egyptian females with clinical information from different geographic regions in Egypt. ⁶¹	ElHefnawi M...Blazyte A	33127537	2021
5	Clinico-pathological and Molecular Spectrum of Mitochondrial Polymerase γ Mutations in a Cohort from India. ⁶¹	Deepha S...Gayathri N	33469851	2021
6	Mitochondrial DNA maintenance disorders in 102 patients from different parts of Russia: Mutational spectrum and phenotypes. ⁶¹	Bychkov IO...Zakharova EY	33486010	2021
7	Progressive External Ophthalmoplegia in Polish Patients-From Clinical Evaluation to Genetic Confirmation. ⁶¹	Kierdaszuk B...Kostera-Pruszczyk A	33396418	2020
8	Strabismus in chronic progressive external ophthalmoplegia. ⁶¹	Kim JY...Hwang JM	33191655	2020
9	Electrophysiological study of neuromuscular junction in congenital myasthenic syndromes, congenital myopathies, and chronic progressive external ophthalmoplegia. ⁶¹	Caldas VM...Zanoteli E	33121830	2020
10	Extraocular Muscle Reveals Selective Vulnerability of Type IIB Fibers to Respiratory Chain Defects Induced by Mitochondrial DNA Alterations. ⁶¹	Oexner RR...Wiesner RJ	33057669	2020
11	Clinical, neuroelectrophysiological and muscular pathological analysis of chronic progressive external ophthalmoplegia. ⁶¹	Lv H...Zhang Y	32742407	2020
12	Surgical management of ptosis in chronic progressive external ophthalmoplegia. ⁶¹	Eshaghi M...Eshaghi S	32847396	2020
13	A PRIMPOL mutation and variants in multiple genes may contribute to phenotypes in a familial case with chronic progressive external ophthalmoplegia symptoms. ⁶¹	Kasamo K...Sano A	31348995	2020
14	MRI findings in SANDO variety of the ataxia-neuropathy spectrum with a novel mutation in POLG (c.3287G>T): A case report. ⁶¹	Parada-Garza JD...Ruiz-Sandoval JL	32600829	2020
15	Increased intra-mitochondrial lipofuscin aggregates with spherical dense body formation in mitochondrial myopathy. ⁶¹	Lu JQ...Tarnopolsky MA	32272361	2020
16	Severe Chronic Progressive External Ophthalmoplegia-Associated Ptosis Successfully Treated With Scleral Lenses. ⁶¹	Cherny C...Dagi Glass LR	32349064	2020
17	Chronic Progressive External Ophthalmoplegia due to a Rare de novo m.12334G>A MT-TL2 Mitochondrial DNA Variant1. ⁶¹	O'Donnell L...Murphy SM	32310184	2020
18	Cognitive Profile of Patients With Mitochondrial Chronic Progressive External Ophthalmoplegia. ⁶¹	Zhang G...Ye Z	32063883	2020
19	Clinical Profile and Outcome of Pediatric Mitochondrial Myopathy in China. ⁶¹	Hu C...Wang Y	33013660	2020
20	Pediatric liver diseases and ocular changes: What hepatologists and ophthalmologists should know and share with each other. ⁶¹	Vitiello L...Vajro P	31843253	2020
21	Neurodegenerative Diseases Associated with Mitochondrial DNA Mutations. ⁶¹	Zhunina OA...Orekhov AN	31755379	2020
22	Genotypes of chronic progressive external ophthalmoplegia in a large adult-onset cohort. ⁶¹	Heighton JN...Tarnopolsky MA	31521625	2019
23	Exophthalmos in Kearns-Sayre syndrome. ⁶¹	Tauber J...Park S	31158487	2019
24	A novel mitochondrial m.4414T>C MT-TM gene variant causing progressive external ophthalmoplegia and myopathy. ⁶¹	Hellebrekers DMEI...Taylor RW	31488384	2019
25	Chronic Progressive External Ophthalmoplegia and Bilateral Vestibular Hypofunction: Balance, Gait, and Eye Movement Before and After Multimodal Chiropractic Care: A Case Study. ⁶¹	Russell BS...Drake ED	31367202	2019
26	Optical coherence tomography findings in chronic progressive external ophthalmoplegia. ⁶¹	Wu Y...Wang ZX	31140991	2019
27	Distinct segregation of the pathogenic m.5667G>A mitochondrial tRNAAsn mutation in extraocular and skeletal muscle in chronic progressive external ophthalmoplegia. ⁶¹	Schlapakow E...Kunz WS	30962064	2019
28	Muscle pain in mitochondrial diseases: a picture from the Italian network. ⁶¹	Filosto M...Mancuso M	30710167	2019
29	Late-onset presentation of POLG1-associated mitochondrial disease. ⁶¹	Meira B...Caetano A	30936349	2019
30	[Mitochondrial diseases]. ⁶¹	Radelfahr F...Klopstock T	30643957	2019
31	CPEO and Mitochondrial Myopathy in a Patient with DGUOK Compound Heterozygous Pathogenetic Variant and mtDNA Multiple Deletions. ⁶¹	Montano V...Mancuso M	30956829	2019
32	A rare case of mitochondriopathy with autosomal dominant progressive external ophthalmoplegia diagnosed through skeletal muscle biopsy. ⁶¹	Bastian AE...Oprisan LA	31263856	2019
33	Appendicular skeletal muscle mass: A more sensitive biomarker of disease severity than BMI in adults with mitochondrial diseases. ⁶¹	Hou Y...Wang Z	31344055	2019
34	Clinical and demographic features of chronic progressive external ophthalmoplegia in a large adult-onset cohort. ⁶¹	Heighton JN...Tarnopolsky MA	29246868	2019
35	Teaching Video NeuroImages: MT-TL1 mutation presenting as chronic progressive external ophthalmoplegia. ⁶¹	Parsons AM...Dhamija R	30665919	2019
36	Strabismus surgery for diplopia in chronic progressive external ophthalmoplegia. ⁶¹	Chatzistefanou KI...Koutsandrea C	29582258	2019
37	Ophthalmoplegia in Mitochondrial Disease. ⁶¹	Lee SJ...Lee YM	30450853	2018
38	Ant1 mutant mice bridge the mitochondrial and serotonergic dysfunctions in bipolar disorder. ⁶¹	Kato TM...Kato T	29892051	2018
39	False positive acetylcholine receptor antibodies in a case of unilateral chronic progressive external ophthalmoplegia: case report and review of literature. ⁶¹	Rajput R...Murray A	29333908	2018
40	Novel mutation in the RNASEH1 gene in a chronic progressive external ophthalmoplegia patient. ⁶¹	Sachdev A...McMullan TFW	30340744	2018
41	Intracranial hypotension mimicking chronic progressive external ophthalmoplegia. ⁶¹	Vahdani K...Garrott H	29300676	2018
42	[Diagnostic and Therapeutic Approaches for Mitochondrial Diseases]. ⁶¹	Radelfahr F...Klopstock T	30248691	2018
43	Phenotypic and Genotypic Heterogeneity of RRM2B Variants. ⁶¹	Finsterer J...Zarrouk-Mahjoub S	29241262	2018
44	Progressive fat replacement of muscle contributes to the disease mechanism of patients with single, large-scale deletions of mitochondrial DNA. ⁶¹	Hedermann G...Vissing J	29567350	2018
45	Disclosing the functional changes of two genetic alterations in a patient with Chronic Progressive External Ophthalmoplegia: Report of the novel mtDNA m.7486G>A variant. ⁶¹	Bacalhau M...Grazina M	29398297	2018
46	[Mitochondrial Dysfunctions and Role of Coenzyme Q10 in Patients with Glaucoma]. ⁶¹	Erb C...Konieczka K	29448286	2018
47	Anesthetic management of a parturient with Kearns-Sayre syndrome, dual-chamber and VVI implantable defibrillator pacemaker/defibrillator, and preeclampsia for cesarean delivery: A case report and review of the literature. ⁶¹	Al Ghamdi A	29416473	2018
48	Mitochondrial Disorder: Kearns-Sayre Syndrome. ⁶¹	Tsang SH...Sharma T	30578503	2018
49	Outcome of epilepsy in patients with mitochondrial disorders: Phenotype genotype and magnetic resonance imaging correlations. ⁶¹	Bindu PS...Taly AB	29272804	2018
50	[Chronic Progressive External Ophthalmoplegia Ptosis: Problems with Diagnostics and Treatment]. ⁶¹	Pfeiffer MJ	29373868	2018

Sources

Genes for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Genes related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 (1 elite genes):

(show all 15)

- Elite gene

- Cancer Census gene in COSMIC

#	Symbol	Description	Category	Score	Evidence	PubMed IDs
1	POLG2	DNA Polymerase Gamma 2, Accessory Subunit	Protein Coding	1326.15	Molecular basis known ⁵⁷ Pathogenic ⁶ Causative variation ⁷³ Genetic Tests ²⁹ DISEASES inferred ¹⁵ GeneCards inferred via : Disorders Variants (show sections)	16685652
2	SUCLA2	Succinate-CoA Ligase ADP-Forming Subunit Beta	Protein Coding	6.69	DISEASES inferred ¹⁵
3	DGUOK	Deoxyguanosine Kinase	Protein Coding	6.57	DISEASES inferred ¹⁵
4	SUCLG1	Succinate-CoA Ligase GDP/ADP-Forming Subunit Alpha	Protein Coding	6.57	DISEASES inferred ¹⁵
5	RRM2B	Ribonucleotide Reductase Regulatory TP53 Inducible Subunit M2B	Protein Coding	6.26	DISEASES inferred ¹⁵
6	INTS2	Integrator Complex Subunit 2	Protein Coding	6.19	DISEASES inferred ¹⁵
7	TWNK	Twinkle MtDNA Helicase	Protein Coding	5.21	DISEASES inferred ¹⁵
8	MPV17	Mitochondrial Inner Membrane Protein MPV17	Protein Coding	5.17	DISEASES inferred ¹⁵
9	SSBP1	Single Stranded DNA Binding Protein 1	Protein Coding	5.15	DISEASES inferred ¹⁵
10	POLG	DNA Polymerase Gamma, Catalytic Subunit	Protein Coding	5.01	DISEASES inferred ¹⁵
11	SLC25A4	Solute Carrier Family 25 Member 4	Protein Coding	4.92	DISEASES inferred ¹⁵
12	IMMT	Inner Membrane Mitochondrial Protein	Protein Coding	4.59	DISEASES inferred ¹⁵
13	MT-ND2	Mitochondrially Encoded NADH:Ubiquinone Oxidoreductase Core Subunit 2	Protein Coding	4.36	DISEASES inferred ¹⁵
14	SOX17	SRY-Box Transcription Factor 17	Protein Coding	4.22	DISEASES inferred ¹⁵
15	TYMP	Thymidine Phosphorylase	Protein Coding	4.08	DISEASES inferred ¹⁵

Sources

Variations for Progressive External Ophthalmoplegia with Mitochondrial Dna...

ClinVar genetic disease variations for Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

⁶ (show all 26)

#	Gene	Name	Type	Significance	ClinVarId	dbSNP ID	GRCh37 Pos	GRCh38 Pos
1	POLG2	NM_007215.4(POLG2):c.1352G>A (p.Gly451Glu)	SNV	Pathogenic	5276	rs104894632	17:62474046-62474046	17:64477929-64477929
2	POLG2	NM_007215.4(POLG2):c.614C>G (p.Pro205Arg)	SNV	Pathogenic	40247	rs397514659	17:62489087-62489087	17:64492970-64492970
3	POLG2	NM_007215.4(POLG2):c.1423_1424del (p.Leu475fs)	Deletion	Pathogenic	40249	rs1568079613	17:62473974-62473975	17:64477857-64477858
4	POLG2	NM_007215.4(POLG2):c.673C>T (p.Arg225Ter)	SNV	Uncertain significance	488881	rs371515325	17:62489028-62489028	17:64492911-64492911
5	POLG2	NM_007215.4(POLG2):c.1343_1347del (p.Thr447_Leu448insTer)	Deletion	Uncertain significance	632287	rs1568079693	17:62474051-62474055	17:64477934-64477938
6	POLG2	NM_007215.4(POLG2):c.-85C>T	SNV	Uncertain significance	324565	rs886053252	17:62493171-62493171	17:64497053-64497053
7	POLG2	NM_007215.4(POLG2):c.-66C>T	SNV	Uncertain significance	324563	rs886053251	17:62493152-62493152	17:64497034-64497034
8	POLG2	NM_007215.4(POLG2):c.1315T>C (p.Phe439Leu)	SNV	Uncertain significance	889720		17:62474083-62474083	17:64477966-64477966
9	POLG2	NM_007215.4(POLG2):c.970-4G>A	SNV	Uncertain significance	889721		17:62481989-62481989	17:64485872-64485872
10	POLG2	NM_007215.4(POLG2):c.381G>A (p.Pro127=)	SNV	Uncertain significance	891271		17:62492706-62492706	17:64496588-64496588
11	POLG2	NM_007215.4(POLG2):c.366G>T (p.Arg122Ser)	SNV	Uncertain significance	891272		17:62492721-62492721	17:64496603-64496603
12	POLG2	NM_007215.4(POLG2):c.358G>A (p.Val120Met)	SNV	Uncertain significance	324561	rs782034872	17:62492729-62492729	17:64496611-64496611
13	POLG2	NM_007215.4(POLG2):c.562+11C>T	SNV	Uncertain significance	384209	rs782336056	17:62492514-62492514	17:64496396-64496396
14	POLG2	NM_007215.4(POLG2):c.674G>A (p.Arg225Gln)	SNV	Likely benign	324559	rs148101254	17:62489027-62489027	17:64492910-64492910
15	POLG2	NM_007215.4(POLG2):c.1417G>A (p.Asp473Asn)	SNV	Likely benign	215019	rs563130304	17:62473981-62473981	17:64477864-64477864
16	POLG2	NM_007215.4(POLG2):c.496C>G (p.Gln166Glu)	SNV	Likely benign	324560	rs370683331	17:62492591-62492591	17:64496473-64496473
17	POLG2	NM_007215.4(POLG2):c.1105A>G (p.Arg369Gly)	SNV	Benign/Likely benign	40248	rs201936720	17:62481850-62481850	17:64485733-64485733
18	POLG2	NM_007215.4(POLG2):c.-61G>A	SNV	Benign	324562	rs552693721	17:62493147-62493147	17:64497029-64497029
19	POLG2	NM_007215.4(POLG2):c.-70T>C	SNV	Benign	892465		17:62493156-62493156	17:64497038-64497038
20	POLG2	NM_007215.4(POLG2):c.-81T>C	SNV	Benign	324564	rs9897606	17:62493167-62493167	17:64497049-64497049
21	POLG2	NM_007215.4(POLG2):c.1269C>T (p.Ser423=)	SNV	Benign	138784	rs61733782	17:62476429-62476429	17:64480312-64480312
22	POLG2	NM_007215.4(POLG2):c.505G>A (p.Ala169Thr)	SNV	Benign	138782	rs1427463	17:62492582-62492582	17:64496464-64496464
23	POLG2	NM_007215.4(POLG2):c.457C>G (p.Leu153Val)	SNV	Benign	215017	rs149446102	17:62492630-62492630	17:64496512-64496512
24	POLG2	NM_007215.4(POLG2):c.397C>T (p.His133Tyr)	SNV	Benign	215023	rs112984118	17:62492690-62492690	17:64496572-64496572
25	POLG2	NM_007215.4(POLG2):c.181G>A (p.Gly61Arg)	SNV	Benign	215022	rs144148008	17:62492906-62492906	17:64496788-64496788
26	POLG2	NM_007215.4(POLG2):c.1247G>C (p.Gly416Ala)	SNV	Benign	138783	rs17850455	17:62476451-62476451	17:64480334-64480334

UniProtKB/Swiss-Prot genetic disease variations for Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

⁷³

#	Symbol	AA change	Variation ID	SNP ID
1	POLG2	p.Gly451Glu	VAR_029364	rs104894632

Sources

Expression for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Search GEO for disease gene expression data for Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4.

Sources

Pathways for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Pathways related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 according to GeneCards Suite gene sharing:

#	Super pathways	Score	Top Affiliating Genes
1	Mitochondrial Gene Expression ¹ Show member pathways Activation of PPARGC1A (PGC-1alpha) by phosphorylation ⁶⁵ Mitochondrial biogenesis ⁶⁵ Mitochondrial transcription initiation ⁶⁵ Mitochondrial transcription termination ⁶⁵ Transcription from mitochondrial promoters ⁶⁵ Transcriptional activation of mitochondrial biogenesis ⁶⁵	11.27	TWNK SSBP1 POLG2
2	Propanoate metabolism ³⁶	10.79	SUCLG1 SUCLA2
3	Valproic Acid Pathway, Pharmacodynamics ⁶⁰ Show member pathways Degradation of GABA ⁶⁵	10.48	SUCLG1 SUCLA2
4	Nucleotide Metabolism ¹	9.9	RRM2B POLG

Sources

GO Terms for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Cellular components related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	mitochondrial matrix	GO:0005759	9.63	TWNK SUCLG1 SUCLA2 SSBP1 POLG2 DGUOK
2	mitochondrial inner membrane	GO:0005743	9.62	SLC25A4 MT-ND2 MPV17 IMMT
3	mitochondrion	GO:0005739	9.4	TWNK SUCLG1 SUCLA2 SSBP1 SLC25A4 RRM2B
4	gamma DNA polymerase complex	GO:0005760	9.26	POLG2 POLG
5	mitochondrial nucleoid	GO:0042645	9.26	TWNK SSBP1 POLG2 POLG

Biological processes related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	DNA biosynthetic process	GO:0071897	9.46	POLG2 POLG
2	tricarboxylic acid cycle	GO:0006099	9.43	SUCLG1 SUCLA2
3	mitochondrion organization	GO:0007005	9.43	TWNK SSBP1 POLG2
4	DNA-dependent DNA replication	GO:0006261	9.4	POLG2 POLG
5	mitochondrion morphogenesis	GO:0070584	9.37	SSBP1 POLG2
6	DNA replication	GO:0006260	9.35	TWNK SSBP1 RRM2B POLG2 POLG
7	mitochondrial genome maintenance	GO:0000002	9.33	TYMP SLC25A4 MPV17
8	DNA unwinding involved in DNA replication	GO:0006268	9.32	TWNK SSBP1
9	mitochondrial DNA replication	GO:0006264	9.02	TWNK SSBP1 RRM2B POLG2 POLG

Molecular functions related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 according to GeneCards Suite gene sharing:

#	Name	GO ID	Score	Top Affiliating Genes
1	DNA-directed DNA polymerase activity	GO:0003887	9.16	POLG2 POLG
2	succinate-CoA ligase (GDP-forming) activity	GO:0004776	8.96	SUCLG1 SUCLA2
3	succinate-CoA ligase (ADP-forming) activity	GO:0004775	8.62	SUCLG1 SUCLA2

Sources

Sources for Progressive External Ophthalmoplegia with Mitochondrial Dna...

¹ BioSystems

² BitterDB

³ CDC

⁴ Cell Signaling Technology

⁵ ClinicalTrials

⁶ ClinVar

⁷ CNVD

⁸ Cochrane Library

⁹ Cosmic

¹⁰ dbSNP

¹¹ DGIdb

¹² Disease Ontology

¹³ diseasecard

¹⁴ DiseaseEnhancer

¹⁵ DISEASES

¹⁶ DrugBank

¹⁷ EFO

¹⁸ ExPASy

¹⁹ FMA

²⁰ GARD

²¹ GeneAnalytics

²² GeneCards

²³ GeneGo (Thomson Reuters)

²⁴ GeneHancer via GeneCards

²⁵ GeneReviews

²⁶ GenomeRNAi

²⁷ GEO DataSets

²⁸ GO

²⁹ GTR

³⁰ HMDB

³¹ HPO

³² ICD10

³³ ICD10 via Orphanet

³⁴ ICD9CM

³⁵ IUPHAR

³⁶ KEGG

³⁷ LifeMap

³⁸ LncRNADisease

³⁹ LOVD

⁴⁰ MalaCards

⁴¹ MedGen

⁴² MedlinePlus

⁴³ MedlinePlus Genetics

⁴⁴ MeSH

⁴⁵ MESH via Orphanet

⁴⁶ MGI

⁴⁷ miR2Disease

⁴⁸ NCBI Bookshelf

⁴⁹ NCI

⁵⁰ NCIt

⁵¹ NDF-RT

⁵² NIH Clinical Center

⁵³ NINDS

⁵⁴ Novoseek

⁵⁵ Novus Biologicals

⁵⁶ OMIM via Orphanet

⁵⁷ OMIM® (Updated 05-Mar-2021)

⁵⁸ Orphanet

⁵⁹ PathCards

⁶⁰ PharmGKB

⁶¹ PubMed

⁶² PubMed Health

⁶³ QIAGEN

⁶⁴ R&D Systems

⁶⁵ Reactome

⁶⁶ Sino Biological

⁶⁷ SNOMED-CT

⁶⁸ SNOMED-CT via HPO

⁶⁹ TGDB

⁷⁰ Tocris

⁷¹ UMLS

⁷² UMLS via Orphanet

⁷³ UniProtKB/Swiss-Prot

⁷⁴ Wikipedia

Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 (PEOA4)

Aliases & Classifications for Progressive External Ophthalmoplegia with Mitochondrial Dna...

MalaCards integrated aliases for Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

Characteristics:

OMIM®:

HPO:

Classifications:

External Ids:

Summaries for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Related Diseases for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Diseases in the Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 1 family:

Diseases related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 via text searches within MalaCards or GeneCards Suite gene sharing:

Graphical network of the top 20 diseases related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

Symptoms & Phenotypes for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Human phenotypes related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

Symptoms via clinical synopsis from OMIM®:

Clinical features from OMIM®:

UMLS symptoms related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

MGI Mouse Phenotypes related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

Drugs & Therapeutics for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Interventional clinical trials:

Genetic Tests for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Genetic tests related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

Anatomical Context for Progressive External Ophthalmoplegia with Mitochondrial Dna...

MalaCards organs/tissues related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

Publications for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Articles related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

Genes for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Genes related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 (1 elite genes):

Variations for Progressive External Ophthalmoplegia with Mitochondrial Dna...

ClinVar genetic disease variations for Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

UniProtKB/Swiss-Prot genetic disease variations for Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4:

Expression for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Pathways for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Pathways related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 according to GeneCards Suite gene sharing:

GO Terms for Progressive External Ophthalmoplegia with Mitochondrial Dna...

Cellular components related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 according to GeneCards Suite gene sharing:

Biological processes related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 according to GeneCards Suite gene sharing:

Molecular functions related to Progressive External Ophthalmoplegia with Mitochondrial Dna Deletions, Autosomal Dominant 4 according to GeneCards Suite gene sharing:

Sources for Progressive External Ophthalmoplegia with Mitochondrial Dna...